IP Library Granted Patent US 10,512,711
Granted Patent B2
US 10,512,711 · App. 14/682,188 · Granted Dec 24, 2019

Articles for tissue regeneration with biodegradable polymer

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,512,711
App. No.
14/682,188
Granted
Dec 24, 2019
Kind
B2
Abstract

The invention is to articles made from extracellular matrix sheets that encase biodegradable polymeric material. Methods of healing wounds or regenerating tissue at sites of defect by placing said articles in mammals are claimed. The biodegradable polymer can change quality upon contact with a physiological parameter such as temperature or pH that causes, for example, a liquid polymer to gel or harden. The degradation of the polymer can be controlled to suit a tissue regeneration or wound healing time course. Additional components such as proteins, cells and drugs can be added to the biopolymer composition.

Claims (9)

1. A method for regenerating mammalian tissue, comprising the steps of:

identifying a defective tissue site in a mammalian structure;

providing a tissue regeneration member comprising an outer tube member, a concentric inner tube member and a biodegradable polymeric emulsion disposed between said outer tube member and said concentric inner tube member,

said concentric inner tube comprising a lumen therethrough that is configured to allow fluid flow therethrough,

said outer tube member comprising first decellularized extracellular matrix (ECM) derived from mammalian liver basement membrane tissue,

said concentric inner tube member comprising second decellularized ECM derived from small intestine submucosa tissue,

said biodegradable polymeric emulsion comprising poly ε-caprolactone and an antibiotic; and

contacting said defective tissue site with said tissue regeneration member, wherein new tissue is regenerated at said defective tissue site.

2. The method of claim 1 , wherein said biodegradable polymeric emulsion further comprises a growth factor selected from the group consisting of transforming growth factor beta (TGF-β), fibroblast growth factor-2 (FGF-2) and vascular epithelial growth factor (VEGF).

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2025
From: CORMATRIX CARDIOVASCULAR, INC.
To: CORVIVO CARDIOVASCULAR, INC.
Reel/Frame 070481/0747 →
RELEASE OF SECURITY INTEREST Recorded Jun 2, 2017
From: MIDCAP FINANCIAL TRUST
To: CORMATRIX CARDIOVASCULAR, INC.
Reel/Frame 042669/0559 →
SECURITY INTEREST Recorded Sep 30, 2015
From: CORMATRIX CARDIOVASCULAR, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 036732/0103 →